Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Roivant Sciences (ROIV) Profit After Tax (2020 - 2025)

Roivant Sciences' Profit After Tax history spans 6 years, with the latest figure at -$313.7 million for Q4 2025.

  • For Q4 2025, Profit After Tax fell 365.68% year-over-year to -$313.7 million; the TTM value through Dec 2025 reached -$635.6 million, down 112.59%, while the annual FY2025 figure was -$729.8 million, 116.22% down from the prior year.
  • Profit After Tax reached -$313.7 million in Q4 2025 per ROIV's latest filing, down from -$166.0 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $5.2 billion in Q4 2023 to a low of -$384.9 million in Q4 2022.
  • Average Profit After Tax over 5 years is $131.4 million, with a median of -$279.9 million recorded in 2024.
  • Peak YoY movement for Profit After Tax: tumbled 1167.12% in 2021, then surged 1439.18% in 2023.
  • A 5-year view of Profit After Tax shows it stood at -$284.5 million in 2021, then crashed by 35.27% to -$384.9 million in 2022, then soared by 1439.18% to $5.2 billion in 2023, then tumbled by 97.71% to $118.1 million in 2024, then tumbled by 365.68% to -$313.7 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Profit After Tax are -$313.7 million (Q4 2025), -$166.0 million (Q3 2025), and -$273.9 million (Q2 2025).